Buscar
01/03/2024
Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain
Vilarrasa, E, Molina-Leyva, A, Martín, V, Coak, E, Truman, I, Wallinger, H, Richardson, C, Martorell, A. Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real-world experience from Spain. Jeadv Clinical Practice. 2024; 3(1)DOI:10.1002/jvc2.237. PMID:. IF:(Q/D).
01/01/2024
[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases
Vilarrasa, E, Nicolau, J, de la Cueva, P, Goday, A, Gallardo, F, Martorell-Calatayud, A, Carrascosa, JM. [Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.10.019. PMID:37918631. IF:(Q/D).
01/01/2024
Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping
Fernández-figueras, MT, Pérez-muñoz, N, Puig, L, Posada-caez, R, Victoria, RB, Henriquez, M, Musulen, E. Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.40172. PMID:38956962. IF:3.700(Q1/2D).
01/01/2024
SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE
Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londoño, A, Lebwohl, M, Nash, P. SAFETY IN PATIENTS WITH LATENT TUBERCULOSIS WHO RECEIVED CONCOMITANT ANTITUBERCULOSIS MEDICATIONS: ANALYSIS OF 11 STUDIES OF GUSELKUMAB IN PSORIATIC DISEASE. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:. PMID:. IF:3.700(Q1/2D).